| Article Index |
|---|
| Abandonment of the Conventional Oncology System:The Daniel Hauser Case. |
| Page 2 |
| Page 3 |
| All Pages |
REFERENCES.
1. White JD. Complementary and alternative medical research: A National Cancer Institute Perspective. Semin Oncol 2002; 29: 546-51.
2. Nahin RL. Use of the best case series to evaluate complementary and alternative therapies for cancer: A systematic review. Semin Oncol 2002; 29: 552-62.
3. Richardson MA, Strauss SE. Complementary and alternative medicine; Opportunities and challenges for cancer management and research. Semin Oncol 2002; 29: 531-45.
4. Cassileth BR. Complementary and alternative cancer medicine. J Clin Oncol 1999;17:44–52.
5. Cassileth BR, Vickers AJ. Complementary and alternative therapies. Urol Clin North Am 2003;30:369–76.
6. Cassileth BR, Deng G. Complementary and alternative therapies. Complementary and alternative therapies for cancer. The Oncologist 2004; 9: 80-9.
7. Montbriand M. Abandoning biomedicine for alternate therapies: Oncology patients' stories. Cancer Nursing 1998;21:36-45.
8. Shumay DM, Maskarinec G, Kakai H, Gotay CC. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract 2001;50: 1067.
9. White MA, Verhoef MJ. Decision-making control: Why men decline treatment for prostate cancer. Integr Cancer Ther 2003;2:217-24.
10. Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: A systematic review. Integr Cancer Ther 2005;4:274-86.
11. Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services. JAMA 1999;282:651–6.
12. Schraub S. Unproven methods in cancer: a worldwide problem. Support Care Cancer 2000;8:10–15.
13. Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: the International Union Against Cancer survey. Cancer 2001: 91: 1390-3.
14. Pal SK, Mittal B. Importance of complementary and alternative cancer therapies in palliative oncology in India. J Altern Complement Med 2003; 9: 811-12.
15. Tovey P, Chatwin J, Ahmad S. Toward an understanding of decision making on complementary and alternative medicine use in poorer countries: the case of cancer care in Pakistan. Integr Cancer Ther 2005; 4: 236-41.
16. Tovey P, Broom A, Chatwin J, Hafeez M, Ahmad S. Patient assessment of effectiveness and satisfaction with traditional medicine, globalized complementary and alternative medicines, and allopathic medicines for cancer in Pakistan. Integr Cancer Ther 2005; 4: 242-8.
17. Travena J, Reeder A. Perceptions of New Zealand Adults about complementary and alternative therapies for cancer treatment. N Z Med J 2005; 118: U1787.
